Colon-26 - Syngeneic Model

 

Rincon Bio performs Colon-26 syngeneic models to test efficacy of immunotherapies.  Please see below for additional information or to request a quote. 

in vivo

Used as a syngeneic model.  Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies 

Colon

Colon-26 cells were derived from a BALB/c mouse.  It is a colorectal cancer line and grows as a subcutaneous model

Request Quote

Receive a quote within one business day for a Colon-26 syngeneic study

Rincon Bio Growth Curve

Colon-26.jpg

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients.  We develop a personal interest in our clients and their studies.